Durvalumab and Lenvatinib in Participants With Advanced and Recurrent Endometrial Carcinoma
Clinical trial NCT04444193 · UNKNOWN
Trial details
- NCT number
- NCT04444193
- Sponsor
- Shanghai First Maternity and Infant Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-31
- Primary completion
- 2021-05-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.